Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varilrix versus Priorix-Tetra efficacy study for prevention of varicella in young children
2004-002676-41Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varicella virus vaccine live and GSK208136 in chickenpox (3 arms), sponsored by GSK. Primary endpoint: Occurrence of confirmed varicella cases. Started Jan 2005; status: completed.
02
Drugs
varicella virus vaccine liveGSK208136
03
Conditions
chickenpox
Beyond the preview
Go deeper on 2004-002676-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002676-41.